The phenomenon affects 1530% of patients who lose more than 15% of body weight within six months, with risk factors including age over 45, baseline low facial volume, and insufficient protein intake during treatment
Enterotoxigenic bacteroidesfragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p
BMI 27 plus prior MI, prior stroke, or symptomatic PAD can qualify under the Bridge criteria
L-carnitine deficiency is uncommon in the general population and typically occurs only in certain circumstances, such as genetic disorders of carnitine metabolism, severe kidney disease requiring dialysis, or strict vegan diets combined with certain medical conditions
Not an MHRA-licensed medicine
Transitioning between vial sizes or formulations If you switch from a 5mg vial to a 10mg vial, or from one compounding source to another, always recalculate your doses from scratch